ATE231549T1 - Verfahren zur konservierung von infektiösen rekombinierenden viren, virale wässrige suspension und ihre medizinische verwendung - Google Patents
Verfahren zur konservierung von infektiösen rekombinierenden viren, virale wässrige suspension und ihre medizinische verwendungInfo
- Publication number
- ATE231549T1 ATE231549T1 AT97933740T AT97933740T ATE231549T1 AT E231549 T1 ATE231549 T1 AT E231549T1 AT 97933740 T AT97933740 T AT 97933740T AT 97933740 T AT97933740 T AT 97933740T AT E231549 T1 ATE231549 T1 AT E231549T1
- Authority
- AT
- Austria
- Prior art keywords
- viruses
- viral
- recombining
- aqueous suspension
- medical use
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9608851A FR2751343B1 (fr) | 1996-07-16 | 1996-07-16 | Procede de conservation de virus recombinants infectieux, suspension aqueuse virale et utilisation comme medicament |
PCT/FR1997/001308 WO1998002522A1 (fr) | 1996-07-16 | 1997-07-15 | Procede de conservation de virus recombinants infectieux, suspension aqueuse virale et utilisation comme medicament |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE231549T1 true ATE231549T1 (de) | 2003-02-15 |
Family
ID=9494078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97933740T ATE231549T1 (de) | 1996-07-16 | 1997-07-15 | Verfahren zur konservierung von infektiösen rekombinierenden viren, virale wässrige suspension und ihre medizinische verwendung |
Country Status (11)
Country | Link |
---|---|
US (2) | US6451256B1 (de) |
EP (1) | EP0853660B1 (de) |
JP (1) | JP3681401B2 (de) |
AT (1) | ATE231549T1 (de) |
AU (1) | AU711409B2 (de) |
CA (1) | CA2232604C (de) |
DE (1) | DE69718612T2 (de) |
DK (1) | DK0853660T3 (de) |
ES (1) | ES2187798T3 (de) |
FR (1) | FR2751343B1 (de) |
WO (1) | WO1998002522A1 (de) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080261289A1 (en) * | 1996-12-13 | 2008-10-23 | Schering-Plough Corporation | Compositions comprising viruses and methods for concentrating virus preparations |
US6544769B1 (en) * | 1996-12-13 | 2003-04-08 | Schering Corporation | Compostions comprising viruses and methods for concentrating virus preparations |
US6759050B1 (en) | 1998-12-03 | 2004-07-06 | Avigen, Inc. | Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
JP2002531418A (ja) * | 1998-12-03 | 2002-09-24 | アビジェン, インコーポレイテッド | アデノ随伴ウイルスの薬学処方物における使用のための賦形剤、およびそれにより構成される薬学処方物 |
US6225289B1 (en) * | 1998-12-10 | 2001-05-01 | Genvec, Inc. | Methods and compositions for preserving adenoviral vectors |
CZ20013560A3 (cs) * | 1999-04-09 | 2002-01-16 | Aventis Pharma S. A. | Tekutý nebo zmrazený přípravek určený k uchování rekombinantních infekčních adenovirů |
FR2791999B1 (fr) * | 1999-04-09 | 2001-09-07 | Aventis Pharma Sa | Composition destinee a la conservation d'adenovirus recombinants infectieux |
JP5118798B2 (ja) * | 2000-03-07 | 2013-01-16 | メルク・シャープ・エンド・ドーム・コーポレイション | アデノウイルス製剤 |
US7456009B2 (en) | 2000-03-07 | 2008-11-25 | Merck & Co., Inc. | Adenovirus formulations |
EP1284287A4 (de) * | 2000-05-10 | 2004-10-13 | Mitsubishi Pharma Corp | Verfahren zur herstellung eines virusvektors |
CA2469623C (en) | 2001-12-12 | 2012-05-29 | F H Faulding & Co Limited | Composition for the preservation of viruses |
PL371261A1 (en) * | 2002-01-18 | 2005-06-13 | Schering Aktiengesellschaft | Stabilized formulations of adenovirus |
KR100507794B1 (ko) * | 2003-02-11 | 2005-08-17 | 한미약품 주식회사 | 고농도 레트로 바이러스 현탁액 제조 방법 |
WO2005052116A2 (en) * | 2003-11-19 | 2005-06-09 | Merck & Co., Inc. | Preservative-containing virus formulations |
US20070207461A1 (en) * | 2004-02-23 | 2007-09-06 | Crucell Holland B.V. | Virus Purification Methods |
GB0502661D0 (en) * | 2005-02-09 | 2005-03-16 | Stabilitech Ltd | A desiccated product |
US8574595B2 (en) * | 2005-04-11 | 2013-11-05 | Crucell Holland B.V. | Virus purification using ultrafiltration |
CN1961961B (zh) * | 2005-11-11 | 2010-05-26 | 深圳市源兴生物医药科技有限公司 | 一种药物制剂及其制备方法 |
MX2011004292A (es) | 2008-11-03 | 2011-05-31 | Crucell Holland Bv | Metodo para la produccion de vectores adenovirales. |
EA023816B1 (ru) | 2010-02-15 | 2016-07-29 | Круселл Холланд Б.В. | СПОСОБ ПРОДУЦИРОВАНИЯ ВИРУСНЫХ ЧАСТИЦ Ad26 |
WO2012038367A1 (en) | 2010-09-20 | 2012-03-29 | Crucell Holland B.V. | Therapeutic vaccination against active tuberculosis |
BR112013004582A2 (pt) | 2010-09-27 | 2016-09-06 | Crucell Holland Bv | método para induzir uma resposta imune em um sujeito contra um antígeno de um parasita que causa a malária |
KR102023207B1 (ko) | 2010-12-02 | 2019-11-25 | 온콜리틱스 바이오테크 인코포레이티드 | 동결건조 바이러스 제형 |
EA201390810A1 (ru) | 2010-12-02 | 2013-09-30 | Онколитикс Байотек Инк. | Жидкие вирусные составы |
AU2013231423B2 (en) | 2012-03-12 | 2018-10-04 | Janssen Vaccines & Prevention B.V. | Batches of recombinant adenovirus with altered terminal ends |
US8932607B2 (en) | 2012-03-12 | 2015-01-13 | Crucell Holland B.V. | Batches of recombinant adenovirus with altered terminal ends |
CN104334188B (zh) | 2012-03-22 | 2016-08-24 | 克鲁塞尔荷兰公司 | 抗rsv疫苗 |
US9119813B2 (en) | 2012-03-22 | 2015-09-01 | Crucell Holland B.V. | Vaccine against RSV |
JP6333814B2 (ja) | 2012-07-10 | 2018-05-30 | トランジェーヌ、ソシエテ、アノニムTransgene S.A. | マイコバクテリア抗原ワクチン |
WO2014009433A1 (en) | 2012-07-10 | 2014-01-16 | Transgene Sa | Mycobacterium resuscitation promoting factor for use as adjuvant |
EA039803B1 (ru) | 2013-04-25 | 2022-03-15 | Янссен Вэксинс Энд Превеншн Б.В. | Стабилизированные растворимые f-полипептиды rsv до слияния |
PE20160045A1 (es) | 2013-06-17 | 2016-02-18 | Crucell Holland Bv | Polipeptidos f de prefusion del virus sincicial respiratorio (rsv) solubles y estabilizados |
EP3092000A1 (de) | 2014-01-09 | 2016-11-16 | Transgene SA | Fusion von heterooligomeren mycobakteriellen antigenen |
US9721484B2 (en) | 2014-06-23 | 2017-08-01 | Humanetics Innovative Solutions, Inc. | Shoulder kit assembly for crash test dummy |
CA3190510A1 (en) | 2014-07-16 | 2016-01-21 | Transgene Sa | Oncolytic virus for expression of immune checkpoint modulators |
US10008130B2 (en) | 2014-09-17 | 2018-06-26 | Humanetics Innovative Solutions, Inc. | Omni-directional shoulder assembly for crash test dummy |
WO2016131945A1 (en) | 2015-02-20 | 2016-08-25 | Transgene Sa | Combination product with autophagy modulator |
SI3283634T1 (sl) | 2015-04-14 | 2019-08-30 | Janssen Vaccines & Prevention B.V. | Rekombinantni adenovirus, ki izraža dva transgena z dvosmernim promotorjem |
PL3319633T3 (pl) | 2015-07-07 | 2021-04-19 | Janssen Vaccines & Prevention B.V. | Szczepionka przeciwko rsv |
EA035909B1 (ru) | 2015-07-07 | 2020-08-31 | Янссен Вэксинс Энд Превеншн Б.В. | Стабилизированные растворимые f-полипептиды rsv до слияния |
JP7088841B2 (ja) | 2016-04-05 | 2022-06-21 | ヤンセン ファッシンズ アンド プリベンション ベーフェー | 安定化された可溶性融合前rsv fタンパク質 |
EA201892250A1 (ru) | 2016-04-05 | 2019-03-29 | Янссен Вэксинс Энд Превеншн Б.В. | Вакцина против rsv |
CA3023322A1 (en) | 2016-05-12 | 2017-11-16 | Janssen Vaccines & Prevention B.V. | Potent and balanced bidirectional promoter |
EP3464331B1 (de) | 2016-05-30 | 2020-10-28 | Janssen Vaccines & Prevention B.V. | Stabilisierte präfusionierte rsv-f-proteine |
BR112018075969A2 (pt) | 2016-06-20 | 2019-04-02 | Janssen Vaccines & Prevention B.V. | promotor bidirecional potente e equilibrado |
EP3484506A1 (de) | 2016-07-14 | 2019-05-22 | Janssen Vaccines & Prevention B.V. | Hpv-impfstoffe |
TW201825511A (zh) | 2016-09-09 | 2018-07-16 | 美商艾斯合顧問有限公司 | 表現免疫檢查點調節子的溶瘤病毒 |
WO2018091680A1 (en) | 2016-11-18 | 2018-05-24 | Transgene Sa | Cowpox-based oncolytic vectors |
WO2018122088A1 (en) | 2016-12-28 | 2018-07-05 | Transgene Sa | Oncolytic viruses and therapeutic molecules |
CN110268061A (zh) | 2017-02-09 | 2019-09-20 | 扬森疫苗与预防公司 | 用于表达异源基因的有效的短启动子 |
WO2018210871A1 (en) | 2017-05-17 | 2018-11-22 | Janssen Vaccines & Prevention B.V. | Methods and compositions for inducing protective immunity against rsv infection |
EP3624844A1 (de) | 2017-05-17 | 2020-03-25 | Janssen Vaccines & Prevention B.V. | Verfahren und zusammensetzungen zur induzierung schützender immunität gegen rsv-infektionen |
WO2019020543A1 (en) | 2017-07-28 | 2019-01-31 | Transgene Sa | ONCOLYTIC VIRUSES EXPRESSING AGENTS TARGETING METABOLIC IMMUNE MODULATORS |
SG11202001458SA (en) | 2017-09-15 | 2020-03-30 | Janssen Vaccines & Prevention Bv | Method for the safe induction of immunity against rsv |
WO2020011754A1 (en) | 2018-07-09 | 2020-01-16 | Transgene | Chimeric vaccinia viruses |
JPWO2020090871A1 (ja) | 2018-10-30 | 2021-10-07 | 国立大学法人 東京大学 | がん治療のための腫瘍溶解性ウイルス |
BR112022014808A2 (pt) | 2020-01-31 | 2022-09-20 | Beth Israel Deaconess Medical Ct Inc | Composições e métodos para vacinas para prevenir e tratar infecção pelo coronavírus-sars-cov-2 |
IL296520A (en) | 2020-03-19 | 2022-11-01 | Trizell Ltd | A virus storage system that responds to temperature |
US20230256057A1 (en) | 2020-07-13 | 2023-08-17 | Transgene | Treatment of immune depression |
CA3207206A1 (en) | 2021-02-01 | 2022-08-04 | Lingfeng LIU | Targeted protein degradation system and use thereof |
JP2024509756A (ja) | 2021-02-19 | 2024-03-05 | ヤンセン ファッシンズ アンド プリベンション ベーフェー | 安定化された融合前rsv fb抗原 |
WO2023020939A1 (en) | 2021-08-17 | 2023-02-23 | Janssen Pharmaceuticals, Inc. | Sars-cov-2 vaccines |
WO2023025899A2 (en) | 2021-08-26 | 2023-03-02 | Transgene | Delivery system for targeting genes of the interferon pathway |
WO2023111725A1 (en) | 2021-12-14 | 2023-06-22 | Janssen Pharmaceuticals, Inc. | Sars-cov-2 vaccines |
WO2023213764A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf |
WO2023213763A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab |
WO2024003353A1 (en) | 2022-07-01 | 2024-01-04 | Transgene | Fusion protein comprising a surfactant-protein-d and a member of the tnfsf |
WO2024038175A1 (en) | 2022-08-18 | 2024-02-22 | Transgene | Chimeric poxviruses |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2668064B1 (fr) * | 1990-10-23 | 1994-12-16 | Transgene Sa | Composition pharmaceutique pour le traitement ou la prevention d'une tumeur maligne. |
US5658779A (en) * | 1992-03-20 | 1997-08-19 | Ligochem, Inc. | Method of adsorbing viruses from fluid compositions |
CA2158935A1 (en) * | 1993-10-12 | 1995-04-20 | Chiron Viagene, Inc. | Methods for preserving recombinant viruses |
FR2711523B1 (fr) * | 1993-10-26 | 1996-02-16 | Transgene Sa | Procédé de préparation d'un aérosol viral. |
US5545555A (en) * | 1994-07-25 | 1996-08-13 | Microtest, Inc. | Microbial transport media |
US5559099A (en) * | 1994-09-08 | 1996-09-24 | Genvec, Inc. | Penton base protein and methods of using same |
US5616487A (en) * | 1994-09-15 | 1997-04-01 | Aastrom Biosciences, Inc. | Stabilized retrovirus compositions |
US5932223A (en) * | 1996-09-26 | 1999-08-03 | Merck & Co., Inc. | Rotavirus vaccine formulations |
-
1996
- 1996-07-16 FR FR9608851A patent/FR2751343B1/fr not_active Expired - Fee Related
-
1997
- 1997-07-15 DE DE69718612T patent/DE69718612T2/de not_active Expired - Lifetime
- 1997-07-15 ES ES97933740T patent/ES2187798T3/es not_active Expired - Lifetime
- 1997-07-15 EP EP97933740A patent/EP0853660B1/de not_active Expired - Lifetime
- 1997-07-15 US US09/043,187 patent/US6451256B1/en not_active Expired - Lifetime
- 1997-07-15 JP JP50569198A patent/JP3681401B2/ja not_active Expired - Lifetime
- 1997-07-15 WO PCT/FR1997/001308 patent/WO1998002522A1/fr active IP Right Grant
- 1997-07-15 DK DK97933740T patent/DK0853660T3/da active
- 1997-07-15 CA CA002232604A patent/CA2232604C/fr not_active Expired - Lifetime
- 1997-07-15 AU AU36986/97A patent/AU711409B2/en not_active Expired
- 1997-07-15 AT AT97933740T patent/ATE231549T1/de active
-
2002
- 2002-08-15 US US10/218,564 patent/US20030082206A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP3681401B2 (ja) | 2005-08-10 |
WO1998002522A1 (fr) | 1998-01-22 |
JP2000500026A (ja) | 2000-01-11 |
FR2751343A1 (fr) | 1998-01-23 |
EP0853660B1 (de) | 2003-01-22 |
ES2187798T3 (es) | 2003-06-16 |
DE69718612D1 (de) | 2003-02-27 |
AU3698697A (en) | 1998-02-09 |
EP0853660A1 (de) | 1998-07-22 |
DK0853660T3 (da) | 2003-05-05 |
CA2232604A1 (fr) | 1998-01-22 |
CA2232604C (fr) | 2005-06-28 |
DE69718612T2 (de) | 2003-11-06 |
FR2751343B1 (fr) | 1998-12-18 |
US20030082206A1 (en) | 2003-05-01 |
US6451256B1 (en) | 2002-09-17 |
AU711409B2 (en) | 1999-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE231549T1 (de) | Verfahren zur konservierung von infektiösen rekombinierenden viren, virale wässrige suspension und ihre medizinische verwendung | |
EA200400376A1 (ru) | Пептиды, полученные из казеина, и их использование в терапии | |
ATE486614T1 (de) | Zusammensetzungen zum einsatz in einer gentherapie zur behandlung von hämophilie | |
EP0431129A4 (en) | Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions | |
ATE451835T1 (de) | Therapeutische verfahren und zusammensetzungen unter verwendung von viren der rekombinanten familie der paramyxoviridae | |
ATE217144T1 (de) | Verfahren und zusammensetzungen zur selektiven modifikation von nukleinsaeuren | |
DE69429260T2 (de) | Adenovirale vektoren tierischen ursprungs und ihre verwendung bei der gentherapie | |
FI961536A0 (fi) | Menetelmä virusten inaktivoimiseksi polyalkeeniglykolin läsnäollessa samoin kuin siten saatu farmaseuttinen valmiste | |
ES2114073T3 (es) | Regeneracion del higado inducida por morfogenes. | |
DE60009146D1 (de) | Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten | |
DE69230643T2 (de) | Methode zur behandlung von viralen infektionen | |
EA199800526A1 (ru) | Производные бензимидазола и их применение для лечения вирусных инфекций | |
ATE298582T1 (de) | Verfahren zur inaktivierung von viren und lyophilisierung von blutproteinen | |
ATE310828T1 (de) | Implantat und vektor zur behandlung von erworbenen krankheiten | |
DK82892D0 (da) | Anvendelse af braadgifte fra bier og hvepse til fremstilling af laegemidler til behandling af infektioner | |
ES2062990T3 (es) | Vacunas, que contienen la proteina f del virus del sida. | |
ATE292177T1 (de) | Gentherapy von lungenkrankheiten | |
ATE255417T1 (de) | Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen | |
DE69231465D1 (de) | Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten | |
DE60040910D1 (de) | Inaktivierte zytokine zur immunisierung | |
DE69006187D1 (de) | Verwendung von Chinolyl- und Isochinolyloxazol-2-onen zur Herstellung eines Arzneimittels zur Verhinderung der Ansteckungsfähigkeit von mit Glykoproteinen umhüllten Viren. | |
RU98117264A (ru) | Способ инактивации вируса иммунодефицита человека и других вирусов в плазме крови человека с сохранением функциональной активности белков плазмы крови |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0853660 Country of ref document: EP |